NVCT
Nuvectis Pharma Inc.
$6.71
+$0.07(+1.05%)
42
Overall
40
Value
45
Tech
--
Quality
Market Cap
$163.69M
Volume
108.72K
52W Range
$4.44 - $11.80
Target Price
$18.00
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| COST OF GOODS SOLD | |||||
| Cost of Revenue | $2.2M | $3.5M | $1.5M | ||
| GROSS PROFIT | |||||
| Gross Profit | $-2.2M | $-3.5M | $-1.5M | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $19.2M | $22.9M | $19.8M | ||
| Research & Development | $13.2M | $15.4M | $12.9M | ||
| Research Expense | $13.2M | $15.4M | $12.9M | ||
| Selling, General & Administrative | $6.0M | $7.5M | $6.9M | ||
| General & Administrative Expenses | $6.0M | $7.5M | $6.9M | ||
| Salaries & Wages | $1.8M | $2.3M | $2.1M | ||
| Other Operating Expenses | $13.0K | $14.0K | $14.0K | ||
| OPERATING INCOME | |||||
| Operating income | $-19.2M | $-22.9M | $-19.8M | ||
| EBITDA | $-19.2M | $-22.3M | $-19.0M | ||
| NON-OPERATING ITEMS | |||||
| Net Non-Operating Interest Income/Expense | $-149.0K | $-637.0K | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | $-19.2M | $-22.3M | $-19.0M | ||
| Pre-Tax Income | $-19.1M | $-22.9M | $-19.8M | ||
| INCOME TAX | |||||
| Tax Provision | -- | -- | -- | ||
| NET INCOME | |||||
| Net Income | $-19.1M | $-22.3M | $-19.0M | ||
| Net Income (Continuing Operations) | $-19.1M | $-22.3M | $-19.0M | ||
| Net Income (Discontinued Operations) | $-19.1M | $-22.3M | $-19.0M | ||
| Net Income (Common Stockholders) | $-19.1M | $-22.3M | $-19.0M | ||
| Normalized Income | -- | -- | $-19.6M | ||
| TOTALS | |||||
| Total Expenses | $19.2M | $26.4M | $21.4M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $12.7M | $15.6M | $17.1M | ||
| Average Shares Outstanding (Diluted) | $12.7M | $15.6M | $17.1M | ||
| Shares Outstanding | $14.8M | $25.5M | $23.4M | ||
| Basic EPS | $-1.51 | $-1.43 | $-1.11 | ||
| Basic EPS (Continuing Operations) | -- | $-1.43 | $-1.11 | ||
| Diluted EPS | $-1.51 | $-1.43 | $-1.11 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.43 | $-1.11 | ||
| OTHER METRICS | |||||
| Insurance And Claims | $1.2M | $842.0K | $606.0K | ||
| Net Income From Other Gains Losses | $149.0K | $637.0K | -- | ||
| Other Gand A | $6.0M | $7.5M | $6.9M | ||
| Rent And Landing Fees | $6.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVCT | $6.71 | +1.1% | 108.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |